Home Collaboration & Exchanges Dr. Polisetty’s IPSA to acquire 80% stake in British College of Ayurveda; will help in upping global appeal for Poly Scientific Ayurveda

Dr. Polisetty’s IPSA to acquire 80% stake in British College of Ayurveda; will help in upping global appeal for Poly Scientific Ayurveda

4 min read
0

In a significant collaboration expected to propel India’s traditional Ayurvedic knowledge to the global stage, Dr Ravishankar Polisetty, the pioneer of Poly Scientific Ayurveda (PSA), has signed an MoU to acquire a majority stake in the British College of Ayurveda (BCA) in the UK. Institute of Polyscientific Ayurveda (IPSA) – a division of Dr Polisetty’s Sai Ganga Panakeia Private Ltd will introduce innovative courses in poly scientific Ayurveda at BCA, UK’s oldest Ayurveda College.

The MoU was signed between Dr. Polisetty and the representatives of BCA, Dr. Mauroof Athique and Dr. Shanta Godagama in the presence of Amarjit Bhamra, Secretariat of the All-Party Parliamentary Group for Traditional Sciences in the UK Parliament.

This strategic collaboration aims to introduce courses on Poly Scientific Ayurveda for a career restoring the natural balance of body, mind and spirit with the wisdom of Ayurveda in the UK and providing advanced training. The initiative is set to bridge the distance between ancient Ayurvedic principles and modern medicine as well as provide holistic care for end-stage disease patients. The alliance with BCA will also facilitate the global propagation of PSA knowledge, providing modern and alternative medical practitioners with comprehensive skills to improve patient care.

“Poly Scientific Ayurveda, which integrates latest technologies and modern medicine with the ancient Indian wisdom of Ayurveda and lifestyle variables, has the potential to become one of the most effective solutions for holistic healthcare. This new partnership will unite leading Ayurvedic experts from the UK and India to strengthen advancements in PSA and help its benefits reach a wider group of people,” says Dr. Polisetty. He adds that the fusion of Ayurveda and allopathy offers enhanced treatment options and outcomes, particularly for patients with end-stage diseases. “Our alliance with BCA will strengthen IPSA’s educational programs and provide modern and alternative medical practitioners with a wide range of skills. PSA will also create a new breed of doctors who treat end-stage diseases more effectively.”

Dr. Polisetty, known for his research in Ayurveda having identified crucial biomarkers such as Vata, Pitta, and Kapha as the base for personalising allopathic and Ayurvedic treatments. He is a trailblazer in the creation of an AI and ML-based IoT platform for integrative healthcare technology.

Load More Related Articles
Load More By Editorial team
Load More In Collaboration & Exchanges
Comments are closed.

Check Also

The tide of growing mistrust in National Testing Agency (NTA) needs to be reversed

Union Education Minister, Dharmendra Pradhan, is facing his first major political and admi…